Form 4: Amgen EVP & CFO Peter H. Griffith Reports Acquisition of Stock Options and Restricted Stock Units

Peter H. Griffith, EVP & CFO of Amgen Inc., reports the acquisition of stock options and restricted stock units (RSUs) in a recent SEC Form 4 filing.

Summary

• Peter H. Griffith, the EVP & CFO of Amgen Inc., filed a Form 4 with the SEC.
• The filing reports the acquisition of 3,919 shares of common stock and 25,334 non-qualified stock options.
• The RSUs were granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vest in four equal annual installments starting May 6, 2026.
• Vested RSUs will be paid in shares of Amgen's common stock on a one-to-one basis.
• The non-qualified stock options also vest in four equal annual installments starting May 6, 2026, and expire on May 6, 2035.
• The exercise price for the stock options is $270.44.
• Griffith also holds 42,246 shares of common stock, including 398 Dividend Equivalents (DEs).

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices and aligns management interests with shareholders.

Positives

• The grant of RSUs and stock options aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The vesting schedule of the RSUs and stock options suggests a focus on long-term value creation for Amgen.

Industry Context

Stock option and RSU grants are a common practice in the pharmaceutical industry to incentivize and retain key executives.

Comparison to Industry Standards

• Companies like Johnson & Johnson, Pfizer, and Merck also utilize stock options and RSUs as part of their executive compensation packages.
• The vesting schedules and grant sizes are generally comparable to industry standards for companies of Amgen's size and market capitalization.

Stakeholder Impact

• Shareholders may view the grant of RSUs and stock options positively as it incentivizes management to improve company performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Form 4, Amgen, Griffith, Stock Options, RSUs, Equity Incentive Plan, Beneficial Ownership, SEC Filing